valuation-and-pricing

DCF valuation requires FCFF or FCFE forecasts, WACC calculation, and terminal value computation. You run WACC and growth sensitivity analysis to generate an evidence-based valuation range for corporate finance decisions like M&A or equity financing.

To derive valuation bands from comparable multiples, apply comparable company (Comps) and comparable transaction (Precedents) multiples. This includes making adjustments for differences and handling outliers to ensure your relative valuation is defensible and accurate.

LBO pricing-to-return analysis translates target IRR and MOIC into a capital structure. This “max offer” logic determines the maximum price you can pay while achieving your required investment return outcomes.

You consolidate DCF, comps, precedents, and LBO results into a weighted football-field summary. This consolidated valuation report format synthesizes multiple methodologies to produce a defensible final pricing recommendation.

Yes, this valuation approach applies to fair value assessment for reporting and value estimation for disputes. It also supports merger target pricing, equity financing valuation, and investment return analysis use cases.

Sensitivity analysis is needed because WACC and terminal growth assumptions heavily impact DCF outcomes. Running WACC and growth sensitivity generates a defensible valuation range rather than a single point estimate, reducing model risk.